The involvement of mTOR pathway in modulating microglial metabolism in AD was also previously suggested by Ulland et al., that identified TREM2 and the downstream mTOR signaling as mediators in maintaining microglial metabolic homeostasis (17). This evidence concerns the gene TREM2 and Alzheimer disease.